サマリー

アレルギー疾患治療薬の世界市場は、2024年の371億4,912万米ドルから2030年には910億6,996万米ドルに成長すると予測され、予測期間中の年間平均成長率（CAGR）は16.12%である。
米国とカナダのアレルギー疾患治療薬市場は、2024年の248億1,798万ドルから2030年には474億4,929万ドルに達すると推定され、2025年から2030年までの予測期間中のCAGRは11.41%である。
アレルギー疾患治療薬の中国市場は、2024年の230億3,336万ドルから2030年には165億2,416万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは38.88%である。
アレルギー疾患向け標的薬の欧州市場は、2024年の65億9,313万ドルから2030年には157億4,486万ドルに達すると推定され、2025年から2030年の予測期間中のCAGRは15.56%である。
アレルギー疾患用標的薬の世界の主要企業には、サノフィ、アッヴィ、ノバルティス、インサイト、ロシュ、アストラゼネカ、GSK、イーライリリー・アンド・カンパニー、アムジェン、ファイザー、レオ・ファーマ、テバ、大塚製薬、マブファームなどが含まれる。2023年、世界の上位5社の売上高シェアは約75.25%であった。

レポートの内容
アレルギー疾患向け標的薬の世界市場規模を概観します。2019年～2023年の過去の市場収益データ、2024年の推定値、2030年までのCAGR予測による世界市場動向の分析。
アレルギー疾患用標的薬の主要生産者を調査し、主要地域・国の収益も掲載しています。アレルギー疾患治療薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに分類して予測するための主要地域/国の注目点をハイライトしています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2019年から2024年までのデータで、アレルギー疾患向け標的薬の収益、市場シェア、主要企業の業界ランキングに焦点を当てています。世界のアレルギー疾患向け標的薬市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。

本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。アレルギー疾患向け標的薬の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
サノフィ、ノバルティス、GSK、アムジェン、アストラゼネカ、ファイザー、TEVA、大塚製薬、ロシュなど、世界の主要企業の詳細な企業プロフィール。

市場セグメンテーション
企業別
サノフィ
アッヴィ
ノバルティス
インサイト
ロシュ
アストラゼネカ
GSK
イーライリリー・アンド・カンパニー
アムジェン
ファイザー
レオ・ファーマ
テバ
大塚製薬
マブファーム
キーメッドバイオサイエンス
ジェネリックス・バイオ
ドラゴンボート製薬
江蘇恒瑞医薬有限公司
サンシャイン国健
Qyunsセラピューティクス
バイオシオン

タイプ別セグメント
IL-4R
TSLP
IL-5
JAK
IgE
IL-13
その他

用途別セグメント
アトピー性皮膚炎
喘息
鼻ポリープを伴う慢性副鼻腔炎
慢性閉塞性肺疾患
その他

地域別
北米
米国
カナダ
中国

アジア（中国を除く）
日本
韓国
東南アジア
インド
オーストラリア

ヨーロッパ
ドイツ
フランス
英国
ロシア
イタリア
その他

ラテンアメリカ
ブラジル
メキシコ
アルゼンチン
コロンビア
その他

中東・アフリカ
サウジアラビア
UAE
トルコ
その他

各章の概要
第1章：報告書のスコープ、各市場セグメント（製品タイプ、用途など）の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 アレルギー疾患治療薬の世界および地域レベルでの売上高各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。
第3章：アレルギー疾患治療薬の標的薬企業鈥の競争環境、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章：各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展の可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけるのに役立つ。
第5章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の収益。
第7章：ヨーロッパ：タイプ別、用途別、国別、セグメント別収益。
第8章：中国：タイプ別、用途別、セグメント別収益。
第9章：アジア（中国を除く）：タイプ別、用途別、地域別、各セグメントの収益。
第10章：中東、アフリカ、ラテンアメリカ：タイプ別、用途別、国別、セグメント別収益。
第11章：主要企業のプロフィールを掲載。製品概要や仕様、アレルギー疾患治療薬の売上高、売上総利益率、最近の開発状況など、市場における主要企業の基本的な状況を詳しく紹介している。
第12章 アナリストの視点/結論

ページTOPに戻る

目次

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Targeted Drugs for Allergic Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1
1.2.2 IL-4R 3
1.2.3 TSLP 4
1.2.4 IL-5 5
1.2.5 JAK 6
1.2.6 IgE 7
1.2.7 IL-13 8
1.3 Market by Application 9
1.3.1 Global Targeted Drugs for Allergic Diseases Market Share by Application: 2019 VS 2023 VS 2030 10
1.3.2 Atopic Dermatitis 12
1.3.3 Asthma 12
1.3.4 Chronic Sinusitis with Nasal Polyps 13
1.3.5 Chronic Obstructive Pulmonary Disease 14
1.3.6 Others 15
1.4 Assumptions and Limitations 19
1.5 Study Objectives 20
1.6 Years Considered 21
2 Global Growth Trends 22
2.1 Global Targeted Drugs for Allergic Diseases Market Perspective (2019-2030) 22
2.2 Global Targeted Drugs for Allergic Diseases Growth Trends by Region 23
2.2.1 Global Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030 24
2.2.2 Targeted Drugs for Allergic Diseases Historic Market Size by Region (2019-2024) 25
2.2.3 Targeted Drugs for Allergic Diseases Forecasted Market Size by Region (2025-2030) 26
2.3 Targeted Drugs for Allergic Diseases Market Dynamics 27
2.3.1 Targeted Drugs for Allergic Diseases Industry Trends 27
2.3.2 Targeted Drugs for Allergic Diseases Market Drivers 28
2.3.3 Targeted Drugs for Allergic Diseases Market Challenges 29
2.3.4 Targeted Drugs for Allergic Diseases Market Restraints 29
3 Competition Landscape by Key Players 30
3.1 Global Revenue Targeted Drugs for Allergic Diseases by Players 30
3.1.1 Global Targeted Drugs for Allergic Diseases Revenue by Players (2019-2024) 30
3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Players (2019-2024) 31
3.2 Global Targeted Drugs for Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 32
3.3 Global Key Players of Targeted Drugs for Allergic Diseases, Ranking by Revenue, 2022 VS 2023 VS 2024 33
3.4 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio 34
3.4.1 Global Targeted Drugs for Allergic Diseases Market Concentration Ratio (CR5) 34
3.4.2 Global Top 5 Companies by Targeted Drugs for Allergic Diseases Revenue in 2023 35
3.5 Global Key Players of Targeted Drugs for Allergic Diseases Head office and Area Served 36
3.6 Global Key Players of Targeted Drugs for Allergic Diseases Product Type 36
3.7 Global Key Players Established Date of Targeted Drugs for Allergic Diseases 37
3.8 Mergers & Acquisitions, Expansion Plans 38
4 Targeted Drugs for Allergic Diseases Breakdown Data by Type 52
4.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Type (2019-2024) 52
4.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Type (2025-2030) 53
5 Targeted Drugs for Allergic Diseases Breakdown Data by Application 55
5.1 Global Targeted Drugs for Allergic Diseases Historic Market Size by Application (2019-2024) 55
5.2 Global Targeted Drugs for Allergic Diseases Forecasted Market Size by Application (2025-2030) 56
6 North America 58
6.1 North America Targeted Drugs for Allergic Diseases Market Size (2019-2030) 58
6.2 North America Targeted Drugs for Allergic Diseases Market Size by Type 58
6.2.1 North America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 58
6.2.2 North America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 59
6.2.3 North America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 60
6.3 North America Targeted Drugs for Allergic Diseases Market Size by Application 60
6.3.1 North America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 60
6.3.2 North America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 61
6.3.3 North America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 62
6.4 North America Targeted Drugs for Allergic Diseases Market Size by Country 62
6.4.1 North America Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 62
6.4.2 North America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 63
6.4.3 North America Targeted Drugs for Allergic Diseases Market Share by Country (2025-2030) 63
6.4.4 United States 64
6.4.5 Canada 65
7 Europe 66
7.1 Europe Targeted Drugs for Allergic Diseases Market Size (2019-2030) 66
7.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type 66
7.2.1 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 66
7.2.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 67
7.2.3 Europe Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 68
7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Application 68
7.3.1 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 68
7.3.2 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 69
7.3.3 Europe Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 70
7.4 Europe Targeted Drugs for Allergic Diseases Market Size by Country 70
7.4.1 Europe Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 70
7.4.2 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 71
7.4.3 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) 71
7.4.4 Germany 73
7.4.5 France 73
7.4.6 U.K. 74
7.4.7 Italy 74
7.4.8 Russia 75
8 China 76
8.1 China Targeted Drugs for Allergic Diseases Market Size (2019-2030) 76
8.2 China Targeted Drugs for Allergic Diseases Market Size by Type 76
8.2.1 China Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 76
8.2.2 China Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 77
8.2.3 China Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 78
8.3 China Targeted Drugs for Allergic Diseases Market Size by Application 78
8.3.1 China Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 78
8.3.2 China Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 79
8.3.3 China Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 80
9 Asia (excluding China) 81
9.1 Asia Targeted Drugs for Allergic Diseases Market Size (2019-2030) 81
9.2 Asia Targeted Drugs for Allergic Diseases Market Size by Type 81
9.2.1 Asia Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 81
9.2.2 Asia Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 82
9.2.3 Asia Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 83
9.3 Asia Targeted Drugs for Allergic Diseases Market Size by Application 83
9.3.1 Asia Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 83
9.3.2 Asia Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 84
9.3.3 Asia Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 85
9.4 Asia Targeted Drugs for Allergic Diseases Market Size by Region 85
9.4.1 Asia Targeted Drugs for Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030 85
9.4.2 Asia Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) 86
9.4.3 Asia Targeted Drugs for Allergic Diseases Market Size by Region (2025-2030) 86
9.4.4 Japan 87
9.4.5 South Korea 88
9.4.6 Southeast Asia 88
9.4.7 India 89
9.4.8 Australia 89
10 Latin America 90
10.1 Latin America Targeted Drugs for Allergic Diseases Market Size (2019-2030) 90
10.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Type 90
10.2.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 90
10.2.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 91
10.2.3 Latin America Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 92
10.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Application 92
10.3.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 92
10.3.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 93
10.3.3 Latin America Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 94
10.4 Latin America Targeted Drugs for Allergic Diseases Market Size by Country 94
10.4.1 Latin America Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 94
10.4.2 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 95
10.4.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) 95
10.4.4 Brazil 96
10.4.5 Mexico 97
10.4.6 Argentina 97
10.4.7 Colombia 98
11 Middle East & Africa 99
11.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size (2019-2030) 99
11.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type 99
11.2.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) 99
11.2.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2025-2030) 100
11.2.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Type (2019-2030) 101
11.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application 101
11.3.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) 101
11.3.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2025-2030) 102
11.3.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Share by Application (2019-2030) 103
11.4 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country 103
11.4.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030 103
11.4.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) 104
11.4.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country (2025-2030) 104
11.4.4 Saudi Arabia 105
11.4.5 UAE 106
11.4.6 Turkey 106
12 Key Players Profiles 107
12.1 Sanofi 107
12.1.1 Sanofi Company Details 107
12.1.2 Sanofi Business Overview 107
12.1.3 Sanofi Targeted Drugs for Allergic Diseases Introduction 108
12.1.4 Sanofi Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 110
12.1.5 Sanofi Recent Development 110
12.2 AbbVie 114
12.2.1 AbbVie Company Details 114
12.2.2 AbbVie Business Overview 115
12.2.3 AbbVie Targeted Drugs for Allergic Diseases Introduction 115
12.2.4 AbbVie Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 117
12.2.5 AbbVie Recent Development 118
12.3 Novartis 123
12.3.1 Novartis Company Details 124
12.3.2 Novartis Business Overview 124
12.3.3 Novartis Targeted Drugs for Allergic Diseases Introduction 125
12.3.4 Novartis Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 127
12.3.5 Novartis Recent Development 127
12.4 Incyte 134
12.4.1 Incyte Company Details 134
12.4.2 Incyte Business Overview 134
12.4.3 Incyte Targeted Drugs for Allergic Diseases Introduction 135
12.4.4 Incyte Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 138
12.4.5 Incyte Recent Development 138
12.5 Roche 141
12.5.1 Roche Company Details 141
12.5.2 Roche Business Overview 141
12.5.3 Roche Targeted Drugs for Allergic Diseases Introduction 143
12.5.4 Roche Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 145
12.5.5 Roche Recent Development 146
12.6 AstraZeneca 148
12.6.1 AstraZeneca Company Details 148
12.6.2 AstraZeneca Business Overview 149
12.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Introduction 149
12.6.4 AstraZeneca Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 154
12.6.5 AstraZeneca Recent Development 154
12.7 GSK 158
12.7.1 GSK Company Details 158
12.7.2 GSK Business Overview 159
12.7.3 GSK Targeted Drugs for Allergic Diseases Introduction 160
12.7.4 GSK Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 161
12.7.5 GSK Recent Development 162
12.8 Eli Lilly and Company 166
12.8.1 Eli Lilly and Company Company Details 167
12.8.2 Eli Lilly and Company Business Overview 167
12.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Introduction 168
12.8.4 Eli Lilly and Company Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 170
12.8.5 Eli Lilly and Company Recent Development 170
12.9 Amgen 174
12.9.1 Amgen Company Details 174
12.9.2 Amgen Business Overview 175
12.9.3 Amgen Targeted Drugs for Allergic Diseases Introduction 176
12.9.4 Amgen Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 177
12.9.5 Amgen Recent Development 177
12.10 Pfizer 179
12.10.1 Pfizer Company Details 180
12.10.2 Pfizer Business Overview 180
12.10.3 Pfizer Targeted Drugs for Allergic Diseases Introduction 181
12.10.4 Pfizer Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 184
12.10.5 Pfizer Recent Development 184
12.11 Leo Pharma 188
12.11.1 Leo Pharma Company Details 188
12.11.2 Leo Pharma Business Overview 188
12.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Introduction 189
12.11.4 Leo Pharma Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 191
12.11.5 Leo Pharma Recent Development 191
12.12 TEVA 193
12.12.1 TEVA Company Details 193
12.12.2 TEVA Business Overview 193
12.12.3 TEVA Targeted Drugs for Allergic Diseases Introduction 194
12.12.4 TEVA Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 195
12.12.5 TEVA Recent Development 196
12.13 Otsuka Pharmaceutical 197
12.13.1 Otsuka Pharmaceutical Company Details 197
12.13.2 Otsuka Pharmaceutical Business Overview 198
12.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Introduction 198
12.13.4 Otsuka Pharmaceutical Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 200
12.13.5 Otsuka Pharmaceutical Recent Development 200
12.14 Mabpharm 201
12.14.1 Mabpharm Company Details 201
12.14.2 Mabpharm Business Overview 202
12.14.3 Mabpharm Targeted Drugs for Allergic Diseases Introduction 203
12.14.4 Mabpharm Revenue in Targeted Drugs for Allergic Diseases Business (2019-2024) 203
12.14.5 Mabpharm Recent Development 204
12.15 Keymed Biosciences 205
12.15.1 Keymed Biosciences Company Details 205
12.15.2 Keymed Biosciences Business Overview 205
12.15.3 Keymed Biosciences Targeted Drugs for Allergic Diseases Introduction 207
12.15.4 Keymed Biosciences Recent Development 208
12.16 Genrix Bio 209
12.16.1 Genrix Bio Company Details 209
12.16.2 Genrix Bio Business Overview 210
12.16.3 Genrix Bio Targeted Drugs for Allergic Diseases Introduction 211
12.16.4 Genrix Bio Recent Development 211
12.17 Dragon Boat Pharmaceutical 212
12.17.1 Dragon Boat Pharmaceutical Company Details 212
12.17.2 Dragon Boat Pharmaceutical Business Overview 212
12.17.3 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Introduction 213
12.18 Jiangsu Hengrui Pharmaceuticals 214
12.18.1 Jiangsu Hengrui Pharmaceuticals Company Details 214
12.18.2 Jiangsu Hengrui Pharmaceuticals Business Overview 214
12.18.3 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Introduction 215
12.18.4 Jiangsu Hengrui Pharmaceuticals Recent Development 217
12.19 Sunshine Guojian 218
12.19.1 Sunshine Guojian Company Details 218
12.19.2 Sunshine Guojian Business Overview 219
12.19.3 Sunshine Guojian Targeted Drugs for Allergic Diseases Introduction 219
12.19.4 Sunshine Guojian Recent Development 220
12.20 Qyuns Therapeutics 221
12.20.1 Qyuns Therapeutics Company Details 221
12.20.2 Qyuns Therapeutics Business Overview 222
12.20.3 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Introduction 222
12.20.4 Qyuns Therapeutics Recent Development 223
12.21 Biosion 224
12.21.1 Biosion Company Details 224
12.21.2 Biosion Business Overview 225
12.21.3 Biosion Targeted Drugs for Allergic Diseases Introduction 225
12.21.4 Biosion Recent Development 226
13 Analyst's Viewpoints/Conclusions 227
14 Appendix 229
14.1 Research Methodology 229
14.1.1 Methodology/Research Approach 229
14.1.2 Data Source 232
14.2 Author Details 235
14.3 Disclaimer 235